Nuclear medicine is composed of two complementary areas, imaging and therapy. Positron
emission tomography (PET) and single-photon imaging, including single-photon emission …

Molecular changes in malignant tissue can lead to an increase in the expression levels of
various proteins or receptors that can be used to target the disease. In oncology, diagnostic …

Copper is one of the most interesting elements for various biomedical applications. Copper
compounds show vast array of biological actions, including anti-inflammatory, anti …

The production of reactor-based medical isotopes is fragile, which has meant supply
shortages from time to time. This paper reviews alternative production methods in the form of …

Purpose: Radioimmunotherapy (RIT) with yttrium-90 (90Y)-labeled anti-CD20 antibody (90Y
ibritumomab tiuxetan; Zevalin, IDEC Pharmaceuticals Corporation, San Diego, CA) has a …

Abstract Objectives: 111In-chimeric L6 (ChL6) monoclonal antibody (mAb)–linked iron oxide
nanoparticle (bioprobes) pharmacokinetics, tumor uptake, and the therapeutic effect of …

Peptide receptor radionuclide therapy (PRRT) using radiolabeled octreotate is an effective
treatment for somatostatin receptor 2–expressing neuroendocrine tumors. The diagnostic …

Antibody (mAb)-linked iron oxide nanoparticles (bioprobes) provide the opportunity to
develop tumor specific thermal therapy (Rx) for metastatic cancer when inductively heated …

Our aim was to report the use of 64Cu and 67Cu as a theranostic pair of radionuclides in
human subjects. An additional aim was to measure whole-organ dosimetry of 64Cu and …

Purpose This study was aimed at establishing a list of radionuclides of interest for nuclear
medicine that can be produced in a high-intensity and high-energy cyclotron. Methods We …